How an East Bay drug maker pivoted from opioids to the cusp of a seizure drug approval


The company could win FDA approval later this year of a drug it bought in fall 2014.

Previous Nonprofit drug developer in uphill battle against Trump administration contraception rule change
Next Portland area breast milk maker scores patent victory in federal court